Description

BSE announces the trading and settlement schedule for the Corporate Debt segment for the period from 01.05.2026 to 31.05.2026, issued by ICCL.

Summary

BSE, through ICCL (Indian Clearing Corporation Limited), has issued the trading and settlement programme for the Corporate Debt segment covering the period from 01 May 2026 to 31 May 2026. The notice (No. 20260408-18) provides the schedule under attachment reference DCM052026.

Key Points

  • Notice No.: 20260408-18, dated 08 April 2026
  • Covers the Corporate Debt segment trading and settlement calendar for May 2026
  • Issued by ICCL under the Settlement/RMS category
  • Attachment reference: DCM052026 contains the detailed programme
  • Applicable to all participants in the BSE Corporate Debt segment

Regulatory Changes

No new regulatory changes introduced. This is a routine periodic notice establishing the operational calendar for the Corporate Debt segment for the upcoming month.

Compliance Requirements

  • Market participants in the Corporate Debt segment must adhere to the trading and settlement dates specified in attachment DCM052026
  • Members should review the schedule to plan their trading and settlement obligations for May 2026
  • Any deviations from the prescribed settlement dates must be in accordance with ICCL guidelines

Important Dates

  • Notice Date: 08 April 2026
  • Programme Period: 01 May 2026 to 31 May 2026
  • Detailed trading and settlement dates are contained in attachment DCM052026

Impact Assessment

This circular has a moderate operational impact on participants in the BSE Corporate Debt segment. It provides clarity on settlement timelines for the month of May 2026, enabling members, clearing members, and institutional investors to plan their debt market transactions accordingly. No market disruption is expected; this is standard monthly scheduling communication from ICCL.

Impact Justification

Routine monthly trading and settlement calendar for the Corporate Debt segment; operationally important for debt market participants but not an exceptional regulatory change.